Immune cells for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new therapy that uses your own immune cells (called TILs) to fight advanced solid tumors. The cells are taken from a tumor, grown in a lab, and then given back to you, potentially helping your body attack the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- Have an advanced solid tumor that has not responded to standard treatments, or for which no standard treatment exists.
- You need at least one tumor that can be surgically removed or biopsied to get immune cells for this treatment.
- You must have at least one other tumor that can be measured on scans (to see if the treatment works).
- You need to be generally active and able to care for yourself (ECOG score 0 or 1).
- You must not have serious heart, lung, or bleeding problems, or untreated brain metastases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment that uses your own immune cells, called TIL, to fight advanced solid tumors. It may be given alone or with another drug that helps the immune system attack cancer. The goal is to see if this treatment is safe and effective for people who have already tried other treatments.
This study tests a new treatment using your body's own immune cells (called tumor-infiltrating lymphocytes) that are taken from your tumor, grown in a lab, and then put back into you. It's for people with advanced solid tumors who have run out of standard options.
This trial tests a new way to treat advanced solid tumors using your own immune cells. Doctors remove a piece of your tumor, grow special immune cells from it in the lab, and then put them back into your body to help fight the cancer.
This trial tests a type of immune cell treatment called TIL (tumor-infiltrating lymphocytes) in people with advanced solid cancers. It may help your immune system better recognize and attack tumors, especially if standard treatments have not worked.
This early-phase study tests a treatment made from your own tumor-fighting immune cells (TIL cells) for advanced solid cancers that have worsened or no longer respond to standard therapy. The main goal is to learn whether it is safe and whether it can shrink tumors for people who have limited options.
This Phase 1 study tests engineered immune cells (TILs/CAR-TILs) made from your tumor to treat advanced solid cancers that have not responded to standard treatments. It may help your immune system better recognize and attack the cancer, but it is mainly focused on safety and early results.
Hear when a new Advanced Solid Tumors Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.